Results

Total Results: 5 records

Showing results for "buprenorphine".

1. Online Training Enables Primary Care Providers in Rural New Mexico to Prescribe Medication for Opioid Use Disorders | Agency for Healthcare Research and Quality
   preventiveservices.ahrq.gov/news/newsroom/case-studies/202304.html
   October 01, 2023 - the MOUD ECHO program to learn about opioid use disorder, treatment using medications (particularly buprenorphine … Participants meet key benchmarks along the way during their training, including getting a license to prescribe buprenorphine … Gallup Indian Medical Center, said, “The MOUD ECHO program showed me how safe and truly lifesaving buprenorphine … We now collaborate extensively with our Emergency Department providers, who are excited to prescribe buprenorphine

2. Emergency Visits for Opioid Use Rose White Treatment for Illicit Drug Use Remained Unchanged (pdf file)
   preventiveservices.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/qdr-data-spotlight-opioids-edvisits-tx.pdf
   August 11, 2021 - ◆ Third, EDs should expand capacity for prescribing buprenorphine. … Buprenorphine is a safe, effective OUD treatment that any licensed clinician who has received a Key … The medications (buprenorphine, buprenorphine/naloxone and/ or naltrexone) are available for treatment … Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized … Barriers and facilitators to clinician readiness to provide emergency department-initiated buprenorphine

3. New Data Resource Provides Insights on Factors Related to Falls | Agency for Healthcare Research and Quality
   preventiveservices.ahrq.gov/news/newsletters/e-newsletter/886.html
   October 01, 2023 - barriers common to conventional OUD treatment and prioritizes “medication first” through prescribing buprenorphine

4. Draft Final Report Estimating the Additional Hospital Inpatient Cost and Mortality Associated with Selected Hospital Acquired Conditions (pdf file)
   preventiveservices.ahrq.gov/sites/default/files/publications2/files/hac-cost-report2017.pdf
   November 01, 2017 - mh]) OR (“analgesics, opioid”[mh] OR opioid*[tiab] OR “Alfentanil”[mh] OR “Alphaprodine”[mh] OR “Buprenorphine … ”[mh] OR “Buprenorphine, Naloxone Drug Combination”[mh] OR “Butorphanol”[mh] OR “Codeine”[mh] OR “Dextromoramide

5. Draft Final Report Estimating the Additional Hospital Inpatient Cost and Mortality Associated with Selected Hospital Acquired Conditions (pdf file)
   preventiveservices.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/hac-cost-report2017.pdf
   November 01, 2017 - mh]) OR (“analgesics, opioid”[mh] OR opioid*[tiab] OR “Alfentanil”[mh] OR “Alphaprodine”[mh] OR “Buprenorphine … ”[mh] OR “Buprenorphine, Naloxone Drug Combination”[mh] OR “Butorphanol”[mh] OR “Codeine”[mh] OR “Dextromoramide